GlassScriptPhysician profile
Chad Michael Caplan
NPI 1245868926
$3,126.15
in general payments reported to CMS, 2019-2025
8 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $488 · 2023: $177 · 2024: $1,976 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,414 · Travel and Lodging: $1,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,413.51 |
| Travel and Lodging | $1,014.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,896.99 | 2022-2024 | Istent Trabecular Micro-Bypass System Model Is3, Idose |
| Alcon Vision LLC | $738.75 | 2021-2025 | Clareon, Hydrus Microstent, Centurion |
| Abbvie INC. | $278.70 | 2023-2025 | Xen Glaucoma Treatment System |
| Allergan, INC. | $99.99 | 2021 | |
| Mallinckrodt Hospital Products INC. | $35.98 | 2024 | Acthar |
| Sight Sciences, INC. | $29.96 | 2024 | Omni Surgical System |
| Dutch Ophthalmic, USA | $22.95 | 2024 | Eva, Combined Machine, Tissueblue |
| Carl Zeiss Meditec USA, INC. | $22.83 | 2024 | Quatera 700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Caplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.